These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188 [TBL] [Abstract][Full Text] [Related]
3. The management of epilepsy in women of child-bearing age and the Australian experience of valproate in pregnancy. Curran MA Clin Exp Neurol; 1987; 23():145-8. PubMed ID: 3117457 [TBL] [Abstract][Full Text] [Related]
4. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. McMahon CL; Braddock SR Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259 [TBL] [Abstract][Full Text] [Related]
5. [Congenital malformations and anticonvulsant therapy in pregnancy]. Shvartzman P; Oren B; Keinan A; Adar H Harefuah; 1986 Apr; 110(8):377-80. PubMed ID: 3744149 [No Abstract] [Full Text] [Related]
6. [Warfarin embryopathy in maternal coumarin therapy for protein S deficiency]. Freude S; Pabinger-Fasching I; Kozel-Lachmann D; Braun F; Pollak A Padiatr Padol; 1991; 26(5):239-41. PubMed ID: 1837605 [TBL] [Abstract][Full Text] [Related]
7. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Gärtner BC; Seifert CB; Michalk DV; Roth B Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045 [TBL] [Abstract][Full Text] [Related]
8. [Is valproic acid teratogenic?]. Robert E; Robert JM; Lapras C Rev Neurol (Paris); 1983; 139(6-7):445-7. PubMed ID: 6412342 [TBL] [Abstract][Full Text] [Related]
9. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related]
10. Epilepsy and pregnancy. Oguni M; Osawa M Epilepsia; 2004; 45 Suppl 8():37-41. PubMed ID: 15610193 [TBL] [Abstract][Full Text] [Related]
12. [Use of valproic acid by pregnant women with epilepsy and the risk of congenital abnormalities in the child]. Niermeijer MF Ned Tijdschr Geneeskd; 1984 Dec; 128(52):2460-1. PubMed ID: 6441121 [No Abstract] [Full Text] [Related]
13. [Psychotropic drugs in pregnancy: uses and risks]. Frühwald S; Ossege M; Thau K; Lenz G Psychiatr Prax; 1998 May; 25(3):126-33. PubMed ID: 9653781 [TBL] [Abstract][Full Text] [Related]
15. Old and new anti-epileptic drugs in pregnancy. Regesta G; Tanganelli P Saudi Med J; 2000 Jan; 21(1):18-23. PubMed ID: 11533745 [TBL] [Abstract][Full Text] [Related]
16. Maternal toxicity of drugs and metabolic disorders--a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data. Khera KS Crit Rev Toxicol; 1987; 17(4):345-75. PubMed ID: 3308323 [TBL] [Abstract][Full Text] [Related]
17. Contraception, pregnancy and lactation in women with epilepsy. Yerby MS Baillieres Clin Neurol; 1996 Dec; 5(4):887-908. PubMed ID: 9068887 [TBL] [Abstract][Full Text] [Related]
18. [Embryopathy due to valproic acid with severe malformations in the central nervous system]. Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769 [TBL] [Abstract][Full Text] [Related]
19. [Alcoholic embryopathy]. Holtorff J; Hinkel GK Z Gesamte Inn Med; 1981 Aug; 36(16):587-93. PubMed ID: 7027654 [TBL] [Abstract][Full Text] [Related]